This is one of my favorite interviews as it tells the story of the phase 1 trials of ibrutinib and idelalisib (CAL 101) by Dr. Furman who was the investigator for them both. See bkoffman.blogspot.com
ASH 2012 Interview with Dr. Rick Furman - CLL Support
ASH 2012 Interview with Dr. Rick Furman
Written by
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
3 Replies
•
Hi Brian,
Thanks for that.
Liked the Leonard Cohen at the IOW I saw him at the O2 centre in London a few years ago. He still has 'it' and it was a great show. Many other musicians there, including David Gilmour from Pink Floyd.
Hi Its interesting to hear how important it is to listen to patients and their views when trying new drugs.
bkoffmanCLL CURE Hero
@jangreen. Agreed. We all learn from each other.
Not what you're looking for?
You may also like...
ASH 2013: INTERVIEW WITH DR. FURMAN RE: IDELALISIB
Hi friends
In my last blog post ( http://bkoffman.blogspot.com ), I have a short and interesting...
ASH 2012 Interview: Dr Jeff Sharman "Why New CLL Treatments Supersede FCR"
Dr Sharman's blog http://www.cll-nhl.com, is well worth keeping an eye on for pertinent but easily...
COVID-19 Vaccinations & Testing Dr. Furman & LLS
We had a CLL Society Zoom session on vaccinations with Dr. Furman April 11.
He discourages getting...
Dr. Furman on the Diminishing Role of FCR
Hi,
As we're getting ready to head to ASH this week, we wanted to post in response to a query that...